NeoChord Names J. Alex Martin Chairman of the Board

ST. LOUIS PARK, Minn., Jan. 23, 2017 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR), today announced the appointment of J. Alex Martin, who currently serves as a director on the Company’s Board, as Board Chairman, effective immediately.  Michael Fulton, M.D., the Company’s current Board Chairman, will remain as an integral member of the Board of Directors.

Read more:  NeoChord Names J. Alex Martin Chairman of the Board